Our results demonstrated that ARL6IP5 is an independent prognosticator of ovarian high-grade serous carcinoma (HGSC) patients with cellular functions of a tumor-suppressor, possibly influencing the development of cisplatin-resistance and progression of OC cells through regulation of DNA repair and apoptosis. This evidence concerns the gene ARL6IP5 and neoplasm.